Haemophilia celebrates 30 years of success

Haemophilia journal maintains strong scientific influence in 2025

Haemophilia— an international journal dedicated to the worldwide exchange of information on inherited bleeding disorders and their comprehensive care—has maintained its impact factor of 3.0 for 2025, reflecting the continued relevance, quality, and influence of the research it publishes for the global bleeding disorders community. An impact factor measures how often, on average, articles published in a journal are cited by other researchers, serving as an indicator of the journal’s scientific influence and standing in its field.

Also available in: Français Español

Maintaining an impact factor of 3.0 highlights the sustained value of the research published in Haemophilia and demonstrates its ongoing contribution to the scientific community. As the official journal of both the World Federation of Hemophilia (WFH) and the European Association for Haemophilia and Allied Disorders (EAHAD), the journal plays a key role in supporting the global exchange of scientific knowledge and best practices. Through original research, reviews, guidelines, and educational content, the journal helps advance evidence-based care and foster international collaboration.

This achievement reflects the dedication of our authors, the expertise and commitment of the peer reviewers who help ensure scientific rigor, and the impact of our journal on the global inherited bleeding disorders community.

—Cedric Hermans, MD, PhD, Editor, Haemophilia, and Vice President, Medical, WFH

As one of the leading scientific journals dedicated exclusively to bleeding disorders and comprehensive care, Haemophilia continues to serve as a trusted source of knowledge for clinicians, researchers, allied healthcare professionals, and patient advocates around the world. The journal provides a platform for the latest advances in diagnosis, treatment, patient outcomes, and emerging therapies, helping to inform clinical practice and improve care for people living with inherited bleeding disorders.

The WFH extends its appreciation to Cedric Hermans, MD, PhD, the journal’s Editor-in-Chief and Vice President, Medical, WFH; and the associate editors; reviewers, authors, and readers whose commitment makes the journal’s continued success possible.

Looking ahead, Haemophilia remains committed to publishing high-quality research that advances evidence-based care and improves outcomes for people living with bleeding disorders worldwide.

To find out more about Haemophilia, please click here.

We’ve accomplished a lot this year, we need your help to continue strong.

Would you like to read more about similar articles?

Disclaimer

The information on the WFH website is provided for general information purposes only. The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.

While every effort has been made to ensure the accuracy of the information on this site, the WFH does not guarantee the information is accurate, and is not responsible in any way whatsoever for damages arising out of the use of this website or any of the information contained herein.

Messages posted to WFH discussion forums, Facebook, Twitter, and other social media platforms do not represent the opinions of the World Federation of Hemophilia, its staff, or Board of Directors. The author of a message is solely responsibility for its content. Information posted on WFH social networks and platforms should never be a substitute for individualized professional medical advice, even when the author has medical qualifications or is considered an authority. Information posted to a discussion group should not be used to diagnose or treat a specific health problem without consulting a qualified healthcare professional. The WFH recommends that you contact your physician or local treatment centre if you have any individual questions or concerns.

References and links to other websites or references to other organizations, products, services, or publications do not constitute endorsement or approval by the WFH. The WFH is not responsible and assumes no liability for the content of any linked websites.

Fraud Alert

Unauthorized solicitations – Warning

The WFH has been made aware of various correspondences—circulated via e-mail and telephone—coming from individuals impersonating WFH staff or falsely stating that they are associated with the WFH. These correspondences, which may seek to obtain money using the name of someone affiliated with the WFH, are fraudulent and come from outside of our organization.

If you receive a suspicious solicitation, exercise extreme caution. In the case of an email, look at the email address to see if it looks suspicious (for example, all WFH emails come from @wfh.org).

We are asking you to remain vigilant, and if you have any doubts about the correspondence, please forward the email to the WFH at [email protected] or call +1 514-875-7944.